Ageing enhances α-synuclein, ubiquitin and endoplasmic reticular stress protein expression in the nigral neurons of Asian Indians

Neurochemistry International

Volumn 57, Issue 5, 2010, Pages 530-539

  Alladi, Phalguni Anand ^a   Mahadevan, Anita ^a   Vijayalakshmi, K ^a   Muthane, Uday ^a   Shankar, S K ^a   Raju, T R ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

Caspase12; Glucose regulated protein 78 (GRP78); Immunofluoresence analysis; Laser scanning confocal microscopy; Ubiquitin; Unbiased stereology

Indexed keywords

ALPHA SYNUCLEIN; CASPASE 12; GLUCOSE REGULATED PROTEIN 78; UBIQUITIN;

AGING; ARTICLE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; INDIAN; NEUROPROTECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEREOLOGY; SUBSTANTIA NIGRA; UPREGULATION; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AGING; ALPHA-SYNUCLEIN; ASIAN CONTINENTAL ANCESTRY GROUP; BLOTTING, WESTERN; CASPASE 12; CHILD; CHILD, PRESCHOOL; ENDOPLASMIC RETICULUM; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HEAT-SHOCK PROTEINS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; INDIA; INFANT; INFANT, NEWBORN; MALE; MESENCEPHALON; MIDDLE AGED; NEURONS; PREGNANCY; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE; UBIQUITIN; YOUNG ADULT;

EID: 77956231550     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2010.06.018     Document Type: Article

References (47)

1. Alladi P.A., Mahadevan A., Shankar S.K., Raju T.R., Muthane U. Expression of GDNF receptors GFRα1 and RET is preserved in substantia nigra pars compacta of aging Asian Indians. J. Chem. Neuroanat. 2010, 40(1):43-52.
2. Alladi P.A., Mahadevan A., Yasha T.C., Raju T.R., Shankar S.K., Muthane U. Absence of age-related changes in nigral dopaminergic neurons of Asian Indians: relevance to lower incidence of Parkinson's disease. Neuroscience 2009, 159:236-245.
3. Alladi P.A., Roy T., Singh N., Wadhwa S. Developmentally regulated expression of c-Fos and c-Jun in the brainstem auditory nuclei of Gallus domesticus is modified by prenatal auditory enrichment. J. Neurobiol. 2005, 62:92-105.
4. Arduino D.M., Esteves A.R., Domingues A.F., Pereira C.M., Cardoso S.M., Oliveira C.R. ER-mediated stress induces mitochondrial-dependent caspases activation in NT2 neuron-like cells. BMB Rep. 2009, 42(11):719-724.
5. Bandopadhyay R., de Belleroche J. Pathogenesis of Parkinson's disease: emerging role of molecular chaperones. Trends Mol. Med. 2010, 16(1):27-36.
6. Beach T.G., Walker D.G., Sue L.I., Newell A., Adler C.C., Joyce J.N. Substantia nigra Marinesco bodies are associated with decreased striatal expression of dopaminergic markers. J. Neuropathol. Exp. Neurol. 2004, 63:329-337.
7. Beach T.G., White C.L., Hamilton R.L., Duda J.E., Iwatsubo T., Dickson D.W., Leverenz J.B., Roncaroli F., Buttini M., Hladik C.L., Sue L.I., Noorigian J.V., Adler C.H. Evaluation of alpha-synuclein immunohistochemical methods used by invited experts. Acta Neuropathol. 2008, 116(September (3)):277-288.
8. Carpenter M.B., Peter P. Nigrostriatal and nigrothalamic fibers in the rhesus monkey. J. Comp. Neurol. 1972, 144:93-115.
9. Chiba-Falek O., Lopez G.J., Nussbaum R.L. Levels of alpha-synuclein mRNA in sporadic Parkinson disease patients. Mov. Disord. 2006, 21:1703-1708.
10. Chu Y., Kordower J.H. Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: is this the target for Parkinson's disease?. Neurobiol. Dis. 2007, 25:134-149.
11. Chung K.K., Zhang Y., Lim K.L., Tanaka Y., Huang H., Gao J., Ross C.A., Dawson V.L., Dawson T.M. Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease. Nat. Med. 2001, 7:1144-1150.
12. Devi L., Raghavendran V., Prabhu B.M., Avadhani N.G., Anandatheerthavarada H.K. Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain. J. Biol. Chem. 2008, 283(14):9089-9100.
13. Duan W., Mattson M.P. Dietary restriction and 2-deoxyglucose administration improve behavioral outcome and reduce degeneration of dopaminergic neurons in models of Parkinson's disease. J. Neurosci. Res. 1999, 57:195-206.
14. Fuchs J., Tichopad A., Golub Y., Munz M., Schweitzer K.J., Wolf B., Berg D., Mueller J.C., Gasser T. Genetic variability in the SNCA gene influences alpha-synuclein levels in the blood and brain. FASEB J. 2008, 22(5):1327-1334.
15. Gai W.P., Yuan H.X., Li X.Q., Power J.T., Blumbergs P.C., Jensen P.H. In situ and in vitro study of colocalization and segregation of alpha-synuclein, ubiquitin, and lipids in Lewy bodies. Exp. Neurol. 2000, 166:324-333.
16. Gertz H.J., Siegers A., Kuchinke J. Stability of cell size and nucleolar size in Lewy body containing neurons of substantia nigra in Parkinson's disease. Brain Res. 1994, 637(1-2):339-341.
17. Gomez-Tortosa E., Newell K., Irizarry M.C., Sanders J.L., Hyman B.T. alpha-Synuclein immunoreactivity in dementia with Lewy bodies: morphological staging and comparison with ubiquitin immunostaining. Acta Neuropathol. 2000, 99:352-357.
18. Greffard S., Verny M., Bonnet A.M., Seilhean D., Hauw J.J., Duyckaerts C. A stable proportion of Lewy body bearing neurons in the substantia nigra suggests a model in which the Lewy body causes neuronal death. Neurobiol. Aging 2010, 31(1):99-103.
19. Halliday G.M., Ophof A., Broe M., Jensen P.H., Kettle E., Fedorow H., Cartwright M.I., Griffiths F.M., Shepherd C.E., Double K.L. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease. Brain 2005, 128:2654-2664.
20. Hirsch E., Graybiel A.M., Agid Y.A. Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease. Nature 1988, 334:345-348.
21. Hitomi J., Katayama T., Taniguchi M., Honda A., Imaizumi K., Tohyama M. Apoptosis induced by endoplasmic reticulum stress depends on activation of caspase-3 via caspase-12. Neurosci. Lett. 2004, 357:127-130.
22. Holtz W.A., O'Malley K.L. Parkinsonian mimetics induce aspects of unfolded protein response in death of dopaminergic neurons. J. Biol. Chem. 2003, 278:19367-19377.
23. Irizarry M.C., Growdon W., Gomez-Isla T., Newell K., George J.M., Clayton D.F., Hyman B.T. Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity. J. Neuropathol. Exp. Neurol. 1998, 57:334-337.
24. Jakowec M.W., Donaldson D.M., Barba J., Petzinger G.M. Postnatal expression of alpha-synuclein protein in the rodent substantia nigra and striatum. Dev. Neurosci. 2001, 23:91-99.
25. Kahle P.J., Neumann M., Ozmen L., Muller V., Jacobsen H., Schindzielorz A., Okochi M., Leimer U., van Der P.H., Probst A., Kremmer E., Kretzschmar H.A., Haass C. Subcellular localization of wild-type and Parkinson's disease-associated mutant alpha-synuclein in human and transgenic mouse brain. J. Neurosci. 2000, 20:6365-6373.
26. Kalai M., Lamkanfi M., Denecker G., Boogmans M., Lippens S., Meeus A., Declercq W., Vandenabeele P. Regulation of the expression and processing of caspase-12. J. Cell Biol. 2003, 162:457-467.
27. Kaufman R.J. Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls. Genes Dev. 1999, 13:1211-1233.
28. Mladenovic Djordjevic A., Perovic M., Tesic V., Tanic N., Rakic L., Ruzdijic S., Kanazir S. Long-term dietary restriction modulates the level of presynaptic proteins in the cortex and hippocampus of the aging rat. Neurochem. Int. 2010, 56:250-255.
29. Muthane U., Jain S., Gururaj G. Hunting genes in Parkinson's disease from the roots. Med. Hypotheses 2001, 57:51-55.
30. Muthane U., Yasha T.C., Shankar S.K. Low numbers and no loss of melanized nigral neurons with increasing age in normal human brains from India. Ann. Neurol. 1998, 43:283-287.
31. Nagamine S., Kabuta T., Furuta A., Yamamoto K., Takahashi A., Wada K. Deficiency of ubiquitin carboxy-terminal hydrolase-L1 (UCH-L1) leads to vulnerability to lipid peroxidation. Neurochem. Int. 2010, 4(May). (Epub ahead of print).
32. Papachroni K.K., Ninkina N., Papapanagiotou A., Hadjigeorgiou G.M., Xiromerisiou G., Papadimitriou A., Kalofoutis A., Buchman V.L. Autoantibodies to alpha-synuclein in inherited Parkinson's disease. J. Neurochem. 2007, 101:749-756.
33. Punia S., Behari M., Govindappa S.T., Swaminath P.V., Jayaram S., Goyal V., Muthane U.B., Juyal R.C., Thelma B.K. Absence/rarity of commonly reported LRRK2 mutations in Indian Parkinson's disease patients. Neurosci. Lett. 2006, 409(2):83-88.
34. Rao R.V., Peel A., Logvinova A., Del Rio G., Hermel E., Yokota T., Goldsmith P.C., Ellerby L.M., Ellerby H.M., Bredesen D.E. Coupling endoplasmic reticulum stress to the cell death program: role of the ER chaperone GRP78. FEBS Lett. 2002, 514:122-128.
35. Rudow G., O'Brien R., Savonenko A.V., Resnick S.M., Zonderman A.B., Pletnikova O., Marsh L., Dawson T.M., Crain B.J., West M.J., Troncoso J.C. Morphometry of the human substantia nigra in ageing and Parkinson's disease. Acta Neuropathol. 2008, 115:461-470.
36. Shehadeh L., Mitsi G., Adi N., Bishopric N., Papapetropoulos S. Expression of Lewy body protein septin 4 in postmortem brain of Parkinson's disease and control subjects. Mov. Disord. 2009, 24(2):204-210.
37. Shobha K., Vijayalakshmi K., Alladi P.A., Nalini A., Sathyaprabha T.N., Raju T.R. Altered in-vitro and in-vivo expression of glial glutamate transporter-1 following exposure to cerebrospinal fluid of amyotrophic lateral sclerosis patients. J. Neurol. Sci. 2007, 254:9-16.
38. Siddiqi Z., Kemper T.L., Killiany R. Age-related neuronal loss from the substantia nigra-pars compacta and ventral tegmental area of the rhesus monkey. J. Neuropathol. Exp. Neurol. 1999, 58:959-971.
39. Siddiqi Z.A., Peters A. The effect of aging on pars compacta of the substantia nigra in rhesus monkey. J. Neuropathol. Exp. Neurol. 1999, 58:903-920.
40. Spillantini M.G., Crowther R.A., Jakes R., Hasegawa M., Goedert M. alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:6469-6473.
41. Takano K., Kitao Y., Tabata Y., Miura H., Sato K., Takuma K., Yamada K., Hibino S., Choshi T., Iinuma M., Suzuki H., Murakami R., Yamada M., Ogawa S., Hori O. A dibenzoylmethane derivative protects dopaminergic neurons against both oxidative stress and endoplasmic reticulum stress. Am. J. Physiol. Cell Physiol. 2007, 293:C1884-C1894.
42. Tong Y., Yamaguchi H., Giaime E., Boyle S., Kopan R., Kelleher R.J., Shen J. Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of {alpha}-synuclein, and apoptotic cell death in aged mice. Proc. Natl. Acad. Sci. U.S.A. 2010, 107(21):9879-9884.
43. Tompkins M.M., Hill W.D. Contribution of somal Lewy bodies to neuronal death. Brain Res. 1997, 775:24-29.
44. Wakabayashi K., Engelender S., Yoshimoto M., Tsuji S., Ross C.A., Takahashi H. Synphilin-1 is present in Lewy bodies in Parkinson's disease. Ann. Neurol. 2000, 47:521-523.
45. Wu J., Kaufman R.J. From acute ER stress to physiological roles of the unfolded protein response. Cell Death Differ. 2006, 13:374-384.
46. Xu J., Kao S.Y., Lee F.J., Song W., Jin L.W., Yankner B.A. Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease. Nat. Med. 2002, 8(6):600-606.
47. Yasuda T., Nihira T., Ren Y.R., Cao X.Q., Wada K., Setsuie R., Kabuta T., Wada K., Hattori N., Mizuno Y., Mochizuki H. Effects of UCH-L1 on alpha-synuclein over-expression mouse model of Parkinson's disease. J. Neurochem. 2009, 108(4):932-944.